Geoff Mulgan

The end of life is likely to be an important focus for innovation. Most people die in hospitals, tied up with tubes and with their bodies pumped full of drugs. Yet most would rather die at home and with more control over the timing and manner of their death.

And I think that still is true of this business - which is basically research and development - that you probably spend more time in planning and training and designing for things to go wrong, and how you cope with them, than you do for things to go right.